Yes...time to build support at $1.40 and keep the support moving higher as the price goes higher. Low floater, great cancer drug in clinical trials and we all know how crazy the share price of biomedical companies can fly. We saw $2 bucks a couple of weeks ago, but wait until we get a positive update on these trials. Things are going to go ballistic on time here.
News 
Market Data 
Discover 
